Direct Comparison of the Safety and Efficacy of Ferric Carboxymaltose versus Iron Dextran in Patients with Iron Deficiency Anemia

Table 3

Subjects who experienced serious adverse events.

Subject	Age/sex	Event	Severity	Causality
FCM
1	63/M	Syncope	Grade 4	None
		Asthenia	Grade 4	None
2	54/F	Abdominal pain	Grade 2	None
3	76/M	Crohn’s disease	Grade 3	Unlikely
		Death	Grade 5	Unlikely
4	83/F	Syncope	Grade 3	None
5	53/M	Colon cancer recurrent	Grade 4	None
DEX
1	32/F	Hypersensitivity	Grade 4	Probable
		Atrial fibrillation	Grade 2	Probable
2	56/F	Vascular pseudoaneurysm	Grade 3	None
3	64/F	Anaphylactic reaction	Grade 4	Probable